Dermata Therapeutics, Inc. — All Filings
341 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001493152-26-012992 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-012991 | Mar 26, 2026 | — |
| 4 | 4 | 0001493152-26-010630 | Mar 17, 2026 | Feb 17, 2026 |
| 8-K | 8-K | 0001493152-26-008037 | Feb 25, 2026 | Feb 23, 2026 |
| SCHEDULE 13D/A | — | 0001493152-26-007792 | Feb 23, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-001308 | Feb 18, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-001248 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000921895-26-000261 | Feb 9, 2026 | — |
| 8-K | 8-K | 0001493152-26-004905 | Feb 3, 2026 | Jan 30, 2026 |
| SCHEDULE 13D/A | — | 0001493152-26-004801 | Feb 2, 2026 | — |
| 424B3 | 424B3 | 0001493152-26-004247 | Jan 29, 2026 | — |
| EFFECT | — | 9999999995-26-000354 | Jan 29, 2026 | — |
| 8-K | 8-K | 0001493152-26-003715 | Jan 27, 2026 | — |
| 424B5 | 424B5 | 0001493152-26-003706 | Jan 27, 2026 | — |
| S-3 | S-3 | 0001493152-26-003259 | Jan 22, 2026 | — |
| SCHEDULE 13D/A | — | 0001493152-26-000967 | Jan 8, 2026 | — |
| D | — | 0001493152-26-000797 | Jan 7, 2026 | — |
| 4 | — | 0001493152-26-000698 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001493152-26-000694 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001493152-26-000696 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001493152-26-000700 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0001493152-26-000695 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001493152-26-000701 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0001493152-26-000702 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001493152-26-000697 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001493152-26-000699 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0001493152-26-000704 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0001493152-26-000703 | Jan 6, 2026 | Jan 2, 2026 |
| SCHEDULE 13G | — | 0001213900-26-000486 | Jan 2, 2026 | — |
| SCHEDULE 13G | — | 0000921895-25-003402 | Dec 30, 2025 | — |
| 4 | — | 0001493152-25-029470 | Dec 29, 2025 | Dec 23, 2025 |
| 8-K | 8-K | 0001493152-25-029364 | Dec 29, 2025 | Dec 23, 2025 |
| 4 | — | 0001493152-25-029468 | Dec 29, 2025 | Dec 23, 2025 |
| S-3 | S-3 | 0001493152-25-024720 | Nov 24, 2025 | — |
| 8-K | 8-K | 0001493152-25-023942 | Nov 18, 2025 | Nov 17, 2025 |
| 8-K | 8-K | 0001493152-25-023419 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-023474 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-021255 | Nov 7, 2025 | — |
| 424B5 | 424B5 | 0001493152-25-021254 | Nov 7, 2025 | — |
| 8-K | 8-K | 0001493152-25-013815 | Sep 17, 2025 | — |
| 8-K | 8-K | 0001493152-25-012952 | Sep 10, 2025 | — |
| 8-K | 8-K | 0001641172-25-025405 | Aug 25, 2025 | Aug 22, 2025 |
| SCHEDULE 13G | — | 0001172661-25-003583 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001641172-25-023570 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-023572 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001641172-25-021501 | Jul 30, 2025 | — |
| 8-K | 8-K | 0001641172-25-019760 | Jul 16, 2025 | Jul 15, 2025 |
| 8-K | 8-K | 0001641172-25-018042 | Jul 7, 2025 | Jul 2, 2025 |
| 8-K | 8-K | 0001641172-25-013823 | Jun 5, 2025 | Jun 3, 2025 |
| ARS | ARS | 0001641172-25-013239 | Jun 2, 2025 | Dec 31, 2024 |